Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Ascendis Pharma A/S changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 248 | 2 | 281 | +35 |
| Shares | 62.9M | 250.2K | 63.8M | +1.15M (+1.8%) |
| Value | $10.9B | $43.2M | $12.7B | +$1.88B (+17.4%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (57)
Institutions that held Ascendis Pharma A/S at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (22)
Institutions that held Ascendis Pharma A/S at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 459,606 | $79.3M |
| Soleus Capital Management, L.P. | 85,000 | $14.7M |
| Walleye Capital LLC | 40,403 | $6.97M |
| Saturn V Capital Management LLC | 38,191 | $6.59M |
| Verition Fund Management LLC | 15,324 | $2.64M |
| Caption Management, LLC | 6,499 | $1.12M |
| XTX Topco Ltd | 6,066 | $1.05M |
| Walleye Trading LLC | 2,605 | $449.6K |
| Algert Global LLC | 2,175 | $375.4K |
| Aigen Investment Management, LP | 1,475 | $254.6K |
| R Squared Ltd | 1,212 | $209.2K |
| Headlands Technologies LLC | 1,196 | $206.4K |
| Skopos Labs, Inc. | 781 | $134.8K |
| Compagnie Lombard Odier SCmA | 224 | $38.7K |
| Bryn Mawr Trust Co | 203 | $35.0K |
| Group One Trading, L.P. | 142 | $24.5K |
| Caitong International Asset Management Co., Ltd | 137 | $23.6K |
| Geneos Wealth Management Inc. | 129 | $22.3K |
| State of Wyoming | 70 | $12.1K |
| Bayforest Capital Ltd | 51 | $8.80K |
| MAI Capital Management | 7 | $1.21K |
| ORG Partners LLC | 6 | $1.03K |
Not filed for Q3 2025 yet (2)
Institutions that held Ascendis Pharma A/S at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Camber Capital Management LP | 250,000 | $43.1M |
| First Horizon Advisors, Inc. | 235 | $40.6K |